Earlier this week, I was truly honored and humbled to receive this award at the #APAAM2024 ⁦ @APApsychiatric Annual Meeting for my contributions to #pharmacogenomics in psychiatry! Following the Q&A round, I felt I should have maybe added one more sentence in the 'take home': Yes, (FDA, EMA...) labeling, guidelines, and expert recommendations are important to consider and should help as orientation. However, at the end of the day, the educated prescriber and the empowered patient must make a joint judgment call if #pharmacogenetic testing should be considered - particularly, before suspecting 'treatment resistance' and before engaging in alternative treatment interventions for #depression.